导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 29.83% | 145/1050 |
| 近一周 | 1.59% | 210/1104 |
| 近一月 | -8.69% | 866/1103 |
| 近一季 | -14.45% | 785/1094 |
| 近半年 | 30.78% | 108/1074 |
| 近一年 | 25.77% | 184/1020 |
| 近两年 | 154.73% | 103/926 |
| 近三年 | 77.63% | 136/834 |
| 成立以来 | 232.79% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.79% 705/1070 |
85.89% 81/1101 |
- - |
- - |
| 2025 | 43.65% 265/1065 |
10.69% 137/1014 |
1.77% 528/1038 |
41.01% 177/1050 |
-9.57% 871/1065 |
| 2024 | 3.08% 496/1011 |
-14.10% 890/960 |
-0.56% 343/983 |
16.00% 178/991 |
4.03% 162/1011 |
| 2023 | -4.82% 199/952 |
29.12% 14/880 |
-7.01% 643/895 |
-14.75% 767/915 |
-7.02% 679/952 |
| 2022 | -20.02% 322/867 |
-24.11% 708/773 |
-6.19% 765/806 |
-3.52% 40/845 |
16.42% 31/867 |
| 2021 | 30.79% 68/740 |
-6.50% 401/580 |
32.90% 39/659 |
-4.49% 331/704 |
10.20% 80/740 |
| 2020 | 50.76% 236/554 |
5.13% 74/419 |
21.85% 253/466 |
4.31% 372/517 |
12.83% 259/554 |
| 2019 | 56.15% 101/410 |
38.90% 73/1146 |
-9.97% 1058/1228 |
15.24% 36/390 |
8.36% 223/410 |
| 2018 | -12.77% 18/349 |
- - |
-20.54% 906/990 |
2.59% 109/1000 |
-5.18% 55/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 中欧电子信息产业沪港深股票A VS. 东吴新产业精选股票A(580008) |